In a mouse model of transgenic diabetes (RIP-LCMV), the combined treatment of anti-NKG2D and antigen-specific regulatory T cells (Tregs) exerted a synergistic preventive effect, preventing diabetes in 75% of virus-infected mice. The gene discussed is KLRK1; the disease is diabetes mellitus.